查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1652697

眼部护理补充剂市场：2025 年至 2032 年全球产业分析、规模、份额、成长、趋势和预测

Eye Care Supplement Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 147 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球眼部护理补充品市场的综合报告。该报告对市场驱动因素、趋势、机会、驱动因素和挑战等关键市场动态进行了全面的评估，并对市场结构提供了详细的见解。本研究报告提供独家资料和统计数据，概述了 2025 年至 2032 年全球眼部护理补充剂市场的预期成长轨迹。

关键见解

  • 眼部护理补充剂市场规模（2025年预测）：183亿美元
  • 预计市场价值（2032年）：251亿美元
  • 全球市场成长率（2025-2032 年复合年增长率）：4.6%

眼部护理补充剂市场报告内容：

眼部护理补充剂是一种旨在改善眼部健康、降低视力相关疾病风险和支持整体眼部功能的膳食补充剂。这些补充剂通常含有维生素（如维生素 A、C 和 E）、矿物质（如锌和硒）、抗氧化剂以及叶黄素和玉米黄质等营养素等成分。该市场的目标客户是那些希望预防黄斑部病变、白内障和干眼症等与老龄化相关的眼部问题以及希望保持一般眼部健康的个人。市场成长的动力包括消费者对眼部健康意识的不断增强、眼部疾病数量的增加以及旨在促进眼部健康的补充剂配方的进步。

市场成长动力：

全球眼部护理补充剂市场受到几个主要因素的推动，包括人口老化，他们更容易患上黄斑部病变、白内障和青光眼等眼睛健康问题。长时间使用萤幕导致的数位眼睛疲劳的增加也导致了对保护和滋养眼睛的补充剂的需求不断增长。此外，消费者的健康意识不断增强，并积极寻求预防措施以避免视力问题，这也推动了人们对眼部健康补充剂的兴趣。补充剂製造技术的进步，例如开发更俱生物利用度和更有效的配方，也在推动市场扩张。实体店和线上平台均提供眼部护理补充品，进一步促进了市场的成长。

市场限制：

儘管成长前景看好，但由于不同地区对补充剂的功效和安全性的标准不同，眼部护理补充剂市场面临监管审查方面的挑战。此外，一些专门的补充剂价格昂贵，这可能会限制它们的可用性，特别是在可支配收入较低的新兴经济体中。缺乏全面的科学证据来支持製造商关于某些眼部护理补充剂有效性的声明，也可能影响消费者的信任。

市场机会：

由于技术创新、人口结构变化和消费者生活方式的改变，眼部护理补充剂市场提供了巨大的商机。监测眼睛健康和补充摄取量的智慧型手机应用程式等数位健康技术的整合正在提高消费者的参与度并为市场参与者开闢新的途径。此外，消费者对天然和有机补充剂的兴趣日益浓厚，为製造商提供了机会，利用对支持眼睛健康的植物来源成分日益增长的需求。策略伙伴关係、研发投资以及引进新的经过临床验证的眼睛护理补充剂对于利用这些新机会至关重要。向中产阶级人口不断增长的新兴市场扩张也为眼部护理补充剂行业的参与者带来了宝贵的成长机会。

本报告探讨的关键问题

  • 推动全球眼部护理补充品市场成长的关键因素有哪些？
  • 最受欢迎的促进眼睛健康的成分和补充剂有哪些？
  • 科技进步如何改变眼部护理补充品市场的竞争格局？
  • 哪些主要企业贡献者，他们采用哪些策略来维持市场竞争力？
  • 全球眼部护理补充剂市场的新兴趋势和未来前景如何？

目录

第一章执行摘要

第二章 市场概况

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
    • 主要趋势
  • 原料生命週期分析
  • 眼部护理补充剂市场：价值链
    • 原物料供应商名单
    • 製造商列表
    • 经销商名单
    • 处方清单
    • 盈利分析
  • 波特五力分析
  • 地缘政治紧张局势：市场影响
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
    • 全球母市场概览
  • 预测因子－相关性和影响力
  • 监管和技术格局

第 3 章 全球眼部护理补充剂市场展望：历史（2019-2023 年）和预测（2025-2032 年）

  • 主要亮点
    • 市场规模（单位）预测
    • 市场规模及与前一年同期比较率
    • 绝对商机
  • 市场规模分析及预测
    • 2019 年至 2023 年历史市场规模分析
    • 目前市场规模预测，2025-2032
  • 全球眼部护理补充剂市场展望：成分
    • 简介/主要发现
    • 2019 年至 2023 年按成分分類的历史市场规模（百万美元）和销售量（单位）分析
    • 2025 年至 2032 年按成分分類的当前市场规模（百万美元）和销售量（单位）预测
      • 叶黄素和玉米黄质
      • Omega-3脂肪酸
      • 抗氧化剂
      • Coenzyme Q10
      • 黄酮类化合物
      • 硫辛酸
      • 虾青素
      • 其他的
  • 市场吸引力分析：原料
  • 全球眼部护理补充品市场展望：适应症
    • 简介/主要发现
    • 2019 年至 2023 年按适应症分類的历史市场规模（百万美元）和销售（单位）分析
    • 目前市场规模（百万美元）和销售（单位）预测（按适应症），2025 年至 2032 年
      • 老龄化黄斑部病变(AMD)
      • 白内障
      • 干眼症
      • 发炎
      • 其他的
  • 市场吸引力分析：指标
  • 全球眼部护理补充剂市场展望：配方
    • 简介/主要发现
    • 2019 年至 2023 年按配方分類的历史市场规模（百万美元）和销售量（单位）分析
    • 2025 年至 2032 年按配方分類的当前市场规模（百万美元）和销售量（单位）预测
      • 药片
      • 胶囊
      • 粉末
      • 软胶囊
      • 液体
  • 市场吸引力分析：配方
  • 全球眼部护理补充剂市场展望：分销管道
    • 简介/主要发现
    • 2019 年至 2023 年按分销管道分類的历史市场规模（百万美元）和销售（单位）分析
    • 2025 年至 2032 年按分销管道分類的当前市场规模（百万美元）和销售（单位）预测
      • 零售药局
      • 医院药房
      • 网路药局
      • 眼科用品店
  • 市场吸引力分析：分销管道

第四章 全球眼部护理补充品市场区域展望

  • 主要亮点
  • 2019 年至 2023 年各地区市场规模与数量（单位）历史分析
  • 2025 年至 2032 年各地区目前市场规模及销售量预测
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和太平洋
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：地区

第 5 章北美眼部护理补充剂市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第 6 章。

第 7 章。

8. 南亚和大洋洲眼部护理补充剂市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第 9 章拉丁美洲眼部护理补充品市场展望：历史（2019-2023 年）与预测（2025-2032 年）

第 10 章中东和非洲眼部护理补充剂市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第十一章 竞争格局

  • 2024 年市场占有率分析
  • 市场结构
    • 市场竞争加剧图
    • 竞争性Omega-3脂肪酸
    • 表观产品体积
  • 公司简介（详情－概述、财务状况、策略、最新发展）
    • The Nature's Bounty Co.
    • Pfizer Inc.
    • Vitabiotics Ltd.
    • Bausch &Lomb
    • Kemin Industries, Inc.
    • Amway International
    • EyeScience
    • Wellbeing Nutrition
    • Nutrivein
    • ZeaVision LLC

第十二章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP33738

Persistence Market Research has recently released a comprehensive report on the global eye care supplement market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global eye care supplement market from 2025 to 2032.

Key Insights:

  • Eye Care Supplement Market Size (2025E): USD 18.3 Billion
  • Projected Market Value (2032F): USD 25.1 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.6%

Eye Care Supplement Market - Report Scope:

Eye care supplements are dietary supplements designed to improve eye health, reduce the risk of vision-related conditions, and support overall eye function. These supplements typically contain ingredients like vitamins (such as Vitamin A, C, and E), minerals (like zinc and selenium), antioxidants, and other nutrients like lutein and zeaxanthin. The market caters to individuals looking to prevent age-related eye issues such as macular degeneration, cataracts, and dry eye syndrome, as well as to those seeking general eye health maintenance. Market growth is driven by increasing consumer awareness regarding the benefits of eye health, rising cases of eye-related disorders, and advancements in supplement formulations aimed at promoting eye wellness.

Market Growth Drivers:

The global eye care supplement market is propelled by several key factors, including an aging population that is more prone to eye health problems such as macular degeneration, cataracts, and glaucoma. The rising prevalence of digital eye strain due to prolonged use of screens has also led to higher demand for supplements that protect and nourish the eyes. Moreover, consumers are becoming more health-conscious and are actively seeking preventative measures to avoid vision impairment, which has spurred interest in eye health supplements. Technological advancements in supplement production, such as the development of more bioavailable and effective formulations, are also driving market expansion. The increased availability of eye care supplements in both physical stores and online platforms has further contributed to the market's growth.

Market Restraints:

Despite promising growth prospects, the eye care supplement market faces challenges related to regulatory scrutiny, with varying standards across regions concerning the efficacy and safety of supplements. Additionally, the high cost of some specialized supplements may limit their accessibility, especially in developing economies with lower disposable incomes. Another restraint is the lack of comprehensive scientific evidence backing the claims made by manufacturers regarding the effectiveness of certain eye care supplements, which could affect consumer confidence.

Market Opportunities:

The eye care supplement market presents significant opportunities driven by technological innovations, demographic shifts, and changing consumer lifestyles. The integration of digital health technologies, such as smartphone apps that monitor eye health and supplement intake, enhances consumer engagement and opens new avenues for market players. Moreover, growing consumer interest in natural and organic supplements provides an opportunity for manufacturers to tap into the expanding demand for plant-based ingredients that support eye health. Strategic partnerships, investment in research and development, and the introduction of new, clinically proven eye care supplements are essential to capitalize on these emerging opportunities. Expanding into emerging markets with growing middle-class populations also presents a valuable growth opportunity for players in the eye care supplement industry.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the eye care supplement market globally?
  • Which ingredients and supplement types are most popular in promoting eye health?
  • How are technological advancements reshaping the competitive landscape of the eye care supplement market?
  • Who are the key players contributing to the eye care supplement market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global eye care supplement market?

Competitive Intelligence and Business Strategy:

Leading players in the global eye care supplement market, including major companies like Pfizer Inc., Amway Corporation, and Herbalife Nutrition, focus on innovation, product diversification, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop effective eye health formulations, targeting specific conditions like macular degeneration, dry eyes, and overall vision support. Collaborations with healthcare providers, nutritionists, and optometrists help boost the credibility of their products and expand market access. Moreover, increasing emphasis on consumer education and the importance of eye care has enhanced awareness, leading to higher adoption of eye care supplements. Investment in clinical trials to validate product claims and the expansion of online retail platforms are crucial strategies for sustaining market growth and meeting consumer demand.

Key Companies Profiled:

  • Pfizer Inc.
  • Amway Corporation
  • Herbalife Nutrition
  • Bausch & Lomb Incorporated
  • Alcon Inc.
  • NaturaLife Labs
  • ZeaVision LLC
  • Nature's Way
  • Swanson Health Products
  • Jarrow Formulas, Inc.

Eye Care Supplement Market Research Segmentation

By Ingredient:

  • Lutein and Zeaxanthin
  • Omega-3 Fatty Acids
  • Antioxidants
  • Coenzyme Q10
  • Flavonoids
  • Alpha-lipoic Acid
  • Astaxanthin

By Indication:

  • Age-related Macular Degeneration (AMD)
  • Cataract
  • Dry Eye syndrome
  • Inflammation

By Formulation:

  • Tablets
  • Capsules
  • Powder
  • Softgels
  • Liquid

By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Ophthalmic Stores

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Eye Care Supplement Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Ingredient Lifecycle Analysis
  • 2.4. Eye Care Supplement Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Formulations
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global Eye Care Supplement Market Outlook: Ingredient
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Ingredient, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
      • 3.3.3.1. Lutein and Zeaxanthin
      • 3.3.3.2. Omega-3 Fatty Acids
      • 3.3.3.3. Antioxidants
      • 3.3.3.4. Coenzyme Q10
      • 3.3.3.5. Flavonoids
      • 3.3.3.6. Alpha-lipoic Acid
      • 3.3.3.7. Astaxanthin
      • 3.3.3.8. Others
  • 3.4. Market Attractiveness Analysis: Ingredient
  • 3.5. Global Eye Care Supplement Market Outlook: Indication
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Indication, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
      • 3.5.3.1. Age-related Macular Degeneration (AMD)
      • 3.5.3.2. Cataract
      • 3.5.3.3. Dry Eye syndrome
      • 3.5.3.4. Inflammation
      • 3.5.3.5. Others
  • 3.6. Market Attractiveness Analysis: Indication
  • 3.7. Global Eye Care Supplement Market Outlook: Formulation
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Formulation, 2019 - 2023
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
      • 3.7.3.1. Tablets
      • 3.7.3.2. Capsules
      • 3.7.3.3. Powder
      • 3.7.3.4. Softgels
      • 3.7.3.5. Liquid
  • 3.8. Market Attractiveness Analysis: Formulation
  • 3.9. Global Eye Care Supplement Market Outlook: Distribution Channel
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2019 - 2023
    • 3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
      • 3.9.3.1. Retail Pharmacies
      • 3.9.3.2. Hospital pharmacies
      • 3.9.3.3. Online pharmacies
      • 3.9.3.4. Ophthalmic Stores
  • 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global Eye Care Supplement Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia & Pacific
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Ingredient
    • 5.3.3. By Indication
    • 5.3.4. By Formulation
    • 5.3.5. By Distribution Channel
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
    • 5.5.1. Lutein and Zeaxanthin
    • 5.5.2. Omega-3 Fatty Acids
    • 5.5.3. Antioxidants
    • 5.5.4. Coenzyme Q10
    • 5.5.5. Flavonoids
    • 5.5.6. Alpha-lipoic Acid
    • 5.5.7. Astaxanthin
    • 5.5.8. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
    • 5.6.1. Age-related Macular Degeneration (AMD)
    • 5.6.2. Cataract
    • 5.6.3. Dry Eye syndrome
    • 5.6.4. Inflammation
    • 5.6.5. Others
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
    • 5.7.1. Tablets
    • 5.7.2. Capsules
    • 5.7.3. Powder
    • 5.7.4. Softgels
    • 5.7.5. Liquid
  • 5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 5.8.1. Retail Pharmacies
    • 5.8.2. Hospital pharmacies
    • 5.8.3. Online pharmacies
    • 5.8.4. Ophthalmic Stores
  • 5.9. Market Attractiveness Analysis

6. Europe Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Ingredient
    • 6.3.3. By Indication
    • 6.3.4. By Formulation
    • 6.3.5. By Distribution Channel
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
    • 6.5.1. Lutein and Zeaxanthin
    • 6.5.2. Omega-3 Fatty Acids
    • 6.5.3. Antioxidants
    • 6.5.4. Coenzyme Q10
    • 6.5.5. Flavonoids
    • 6.5.6. Alpha-lipoic Acid
    • 6.5.7. Astaxanthin
    • 6.5.8. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
    • 6.6.1. Age-related Macular Degeneration (AMD)
    • 6.6.2. Cataract
    • 6.6.3. Dry Eye syndrome
    • 6.6.4. Inflammation
    • 6.6.5. Others
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
    • 6.7.1. Tablets
    • 6.7.2. Capsules
    • 6.7.3. Powder
    • 6.7.4. Softgels
    • 6.7.5. Liquid
  • 6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 6.8.1. Retail Pharmacies
    • 6.8.2. Hospital pharmacies
    • 6.8.3. Online pharmacies
    • 6.8.4. Ophthalmic Stores
  • 6.9. Market Attractiveness Analysis

7. East Asia Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Ingredient
    • 7.3.3. By Indication
    • 7.3.4. By Formulation
    • 7.3.5. By Distribution Channel
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
    • 7.5.1. Lutein and Zeaxanthin
    • 7.5.2. Omega-3 Fatty Acids
    • 7.5.3. Antioxidants
    • 7.5.4. Coenzyme Q10
    • 7.5.5. Flavonoids
    • 7.5.6. Alpha-lipoic Acid
    • 7.5.7. Astaxanthin
    • 7.5.8. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
    • 7.6.1. Age-related Macular Degeneration (AMD)
    • 7.6.2. Cataract
    • 7.6.3. Dry Eye syndrome
    • 7.6.4. Inflammation
    • 7.6.5. Others
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
    • 7.7.1. Tablets
    • 7.7.2. Capsules
    • 7.7.3. Powder
    • 7.7.4. Softgels
    • 7.7.5. Liquid
  • 7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 7.8.1. Retail Pharmacies
    • 7.8.2. Hospital pharmacies
    • 7.8.3. Online pharmacies
    • 7.8.4. Ophthalmic Stores
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Ingredient
    • 8.3.3. By Indication
    • 8.3.4. By Formulation
    • 8.3.5. By Distribution Channel
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
    • 8.5.1. Lutein and Zeaxanthin
    • 8.5.2. Omega-3 Fatty Acids
    • 8.5.3. Antioxidants
    • 8.5.4. Coenzyme Q10
    • 8.5.5. Flavonoids
    • 8.5.6. Alpha-lipoic Acid
    • 8.5.7. Astaxanthin
    • 8.5.8. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
    • 8.6.1. Age-related Macular Degeneration (AMD)
    • 8.6.2. Cataract
    • 8.6.3. Dry Eye syndrome
    • 8.6.4. Inflammation
    • 8.6.5. Others
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
    • 8.7.1. Tablets
    • 8.7.2. Capsules
    • 8.7.3. Powder
    • 8.7.4. Softgels
    • 8.7.5. Liquid
  • 8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 8.8.1. Retail Pharmacies
    • 8.8.2. Hospital pharmacies
    • 8.8.3. Online pharmacies
    • 8.8.4. Ophthalmic Stores
  • 8.9. Market Attractiveness Analysis

9. Latin America Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Ingredient
    • 9.3.3. By Indication
    • 9.3.4. By Formulation
    • 9.3.5. By Distribution Channel
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
    • 9.5.1. Lutein and Zeaxanthin
    • 9.5.2. Omega-3 Fatty Acids
    • 9.5.3. Antioxidants
    • 9.5.4. Coenzyme Q10
    • 9.5.5. Flavonoids
    • 9.5.6. Alpha-lipoic Acid
    • 9.5.7. Astaxanthin
    • 9.5.8. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
    • 9.6.1. Age-related Macular Degeneration (AMD)
    • 9.6.2. Cataract
    • 9.6.3. Dry Eye syndrome
    • 9.6.4. Inflammation
    • 9.6.5. Others
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
    • 9.7.1. Tablets
    • 9.7.2. Capsules
    • 9.7.3. Powder
    • 9.7.4. Softgels
    • 9.7.5. Liquid
  • 9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 9.8.1. Retail Pharmacies
    • 9.8.2. Hospital pharmacies
    • 9.8.3. Online pharmacies
    • 9.8.4. Ophthalmic Stores
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa Eye Care Supplement Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Ingredient
    • 10.3.3. By Indication
    • 10.3.4. By Formulation
    • 10.3.5. By Distribution Channel
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Ingredient, 2025 - 2032
    • 10.5.1. Lutein and Zeaxanthin
    • 10.5.2. Omega-3 Fatty Acids
    • 10.5.3. Antioxidants
    • 10.5.4. Coenzyme Q10
    • 10.5.5. Flavonoids
    • 10.5.6. Alpha-lipoic Acid
    • 10.5.7. Astaxanthin
    • 10.5.8. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2025 - 2032
    • 10.6.1. Age-related Macular Degeneration (AMD)
    • 10.6.2. Cataract
    • 10.6.3. Dry Eye syndrome
    • 10.6.4. Inflammation
    • 10.6.5. Others
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Formulation, 2025 - 2032
    • 10.7.1. Tablets
    • 10.7.2. Capsules
    • 10.7.3. Powder
    • 10.7.4. Softgels
    • 10.7.5. Liquid
  • 10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 10.8.1. Retail Pharmacies
    • 10.8.2. Hospital pharmacies
    • 10.8.3. Online pharmacies
    • 10.8.4. Ophthalmic Stores
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Omega-3 Fatty Acids
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. The Nature's Bounty Co.
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Pfizer Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Vitabiotics Ltd.
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Bausch & Lomb
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Kemin Industries, Inc.
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Amway International
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. EyeScience
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Wellbeing Nutrition
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Nutrivein
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. ZeaVision LLC
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations